50 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Article Searches
BMY or AZN: Which Is the Better Value Stock Right Now? http://www.zacks.com/stock/news/847195/bmy-or-azn-which-is-the-better-value-stock-right-now?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_3-847195 Mar 31, 2020 - BMY vs. AZN: Which Stock Is the Better Value Option?
Top Ranked Income Stocks to Buy for March 31st http://www.zacks.com/commentary/847055/top-ranked-income-stocks-to-buy-for-march-31st?cid=CS-ZC-FT-zacks_1_rank_additions-847055 Mar 31, 2020 - Top Ranked Income Stocks to Buy for March 31st
AVEO Stops AML Study on Ficlatuzumab Amid Coronavirus Pandemic http://www.zacks.com/stock/news/845462/aveo-stops-aml-study-on-ficlatuzumab-amid-coronavirus-pandemic?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-845462 Mar 30, 2020 - AVEO ceases the phase II CyFi-2 study on ficlatuzumab plus high-dose cytarabine for treating patients with relapsed/refractory acute myeloid leukemia to combat the COVID-19 outbreak.
Are You Looking for a High-Growth Dividend Stock? Bristol-Myers Squibb (BMY) Could Be a Great Choice http://www.zacks.com/stock/news/845228/are-you-looking-for-a-high-growth-dividend-stock-bristol-myers-squibb-bmy-could-be-a-great-choice?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_5-845228 Mar 30, 2020 - Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Bristol-Myers Squibb (BMY) have what it takes? Let's find out.
AstraZeneca's Imfinzi Gets FDA Nod for SCLC Label Expansion http://www.zacks.com/stock/news/845152/astrazenecas-imfinzi-gets-fda-nod-for-sclc-label-expansion?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-845152 Mar 30, 2020 - AstraZeneca's (AZN) Imfinzi gets FDA approval as first-line treatment for extensive-stage small cell lung cancer patients. A phase III study on Farxiga in CKD patients meets endpoint earlier than expected.
Sanofi Begins Kevzara Study for Severe Coronavirus Infection http://www.zacks.com/stock/news/845439/sanofi-begins-kevzara-study-for-severe-coronavirus-infection?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-845439 Mar 30, 2020 - Sanofi (SNY) begins treatment in a second phase II/III study evaluating its rheumatoid arthritis drug Kevzara to treat patients with severe COVID-19 outside the United States.
4 Reasons Drug Stocks Are a Buy Right Now https://www.fool.com/investing/2020/03/30/4-reasons-drug-stocks-are-a-buy-right-now.aspx?source=iedfolrf0000001 Mar 30, 2020 - Drug developers took center stage as the world looks to these companies to deliver an answer to COVID-19.
Bristol Myers (BMY) Clinches FDA Nod for MS Drug Zeposia http://www.zacks.com/stock/news/838749/bristol-myers-bmy-clinches-fda-nod-for-ms-drug-zeposia?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-838749 Mar 27, 2020 - The FDA approves Bristol Myers' (BMY) Zeposia for the treatment of adults with relapsing forms of multiple sclerosis.
3 Dirt-Cheap Healthcare Stocks to Buy Right Now https://www.fool.com/investing/2020/03/27/3-dirt-cheap-healthcare-stocks-to-buy-right-now.aspx?source=iedfolrf0000001 Mar 27, 2020 - Bargain prices and tremendous growth prospects make these stocks really attractive.
Company News for Mar 27, 2020 http://www.zacks.com/stock/news/838357/company-news-for-mar-27-2020?cid=CS-ZC--corporate_summary-838357 Mar 27, 2020 - Companies in the news are: BMY, WORK, SIG, FDS

Pages: 12345

<<<Page 4